Alternatives to Generate Biomedicines

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Global biopharmaceutical company focused on oncology and neuroscience treatments.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-driven drug discovery company developing novel medicines for unmet patient needs.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Biotechnology company developing cell and gene therapies for serious diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

A vertically-integrated procurement platform for the life sciences industry.

A global leader in clinical pharmacology and bioanalytical sciences.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered knowledge discovery for life sciences.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Engineering scalable gene therapies for broader patient populations.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Pioneering vision restoration therapies for severe retinal degenerations.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

Developing first-in-class oral therapy for BK polyomavirus infections.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Platform designed to cut cell and gene therapy production costs.

Develops and distributes bioreactor technology for stem cell cultivation.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

AI-enabled technology for cell biology research and biopharma development.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Developing and manufacturing laminin-based cell culture substrates for advanced cell therapies and drug discovery.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Developing human microbiology models for drug discovery.

AI-powered email management and scientific research platforms.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Developing novel immunotherapies and diagnostics for cancer.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A biotechnology company developing genetic therapies for rare disorders.

Developing gene editing therapies to lower cholesterol.

AI-driven biotech company engineering novel proteins for therapeutics and sustainability.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.